COVID-19 in people living with human immunodeficiency virus: A case series of 33 patients [not peer reviewed]
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-05-05
Type
Journal Article
Author
Georg Haerter
Author
Christoph D. Spinner
Author
Julia Roider
Author
Markus Bickel
Author
Ivanka Krznaric
Author
Stephan Grunwald
Author
Farhad Schabaz
Author
Daniel Gillor
Author
Nils Postel
Author
Matthias C. Mueller
Author
Markus Mueller
Author
Katja Roemer
Author
Knud Schewe
Author
Christian Hoffmann
URL
https://www.medrxiv.org/content/10.1101/2020.04.28.20073767v1
Rights
© 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.
Pages
2020.04.28.20073767
Publication
medRxiv The Preprint Server for Health Sciences
Date
01/05/2020
Extra
Publisher: Cold Spring Harbor Laboratory Press
DOI
10.1101/2020.04.28.20073767
Accessed
2020-05-05 20:33:00
Library Catalog
www.medrxiv.org
Language
en
Abstract
Data on people living with human immunodeficiency virus (PLWH) in the current SARS-CoV-2 pandemic is still scarce. This case series of 33 PLWH patients with COVID-19 reveals symptoms and outcome in this special population. Three out of 32 patients with documented outcome died (9%). However, 91% of the patients recovered and 76% have been classified as mild cases, indicating that there is no excess morbidity and mortality among PLWH with symptomatic COVID-19. All patients were on antiretroviral treatment, of them 22 on tenofovir-containing regimen, and 4 on the protease inhibitor darunavir.
Short Title COVID-19 in people living with human immunodeficiency virus